ThinPrep® Imaging Pap reflex HPV DNA
Use
Liquid based Pap testing using the ThinPrep® Imaging System is intended for screening and detection of cervical cancer, pre‑cancerous lesions, and atypical cells as defined by The Bethesda System; if cytologic result is ASCUS, reflex testing for high‑risk HPV DNA is performed to assess risk for HPV‑associated cervical epithelial changes. Pap screening is not reliable for endometrial cancer detection.
Special Instructions
Not provided.
Limitations
Pap test is a screening test subject to both false positive and false negative interpretations. Adequate sampling of ectocervical, endocervical or vaginal cells is necessary. Use of lubricating jelly may interfere with cytologic interpretation. Unlabeled vial, leakage during transport, or mismatched patient identifiers may result in specimen rejection.
Methodology
Automated Analyzer
Biomarkers
Result Turnaround Time
10 days
Related Documents
For more information, please review the documents below
Specimen
Tissue
Volume
Not provided
Minimum Volume
Not provided
Container
PreservCyt® vial
Collection Instructions
Pap sample (gynecologic sample collected in routine manner per NCCLS guidelines) rinsed into PreservCyt® alcohol‑based preservative/transport medium.
Causes for Rejection
Unlabeled vial; leakage during transport; mismatch between vial name and requisition
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 21 days |